Wird geladen...
Customized Targeted Therapy in Hodgkin Lymphoma: Hype or Hope?
Although the majority of patients with Hodgkin lymphoma (HL) are cured with primary therapy, patients with primary refractory disease or relapse after initial treatment have poor outcomes and represent an unmet medical need. Recent advances in unraveling the biology of HL have yielded a plethora of...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4023679/ https://ncbi.nlm.nih.gov/pubmed/24287071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2013.10.004 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|